Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo. 2018

Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba City, 305-8572, Japan.

BACKGROUND Melanoma is one of the most invasive and aggressive types of cancer with a very poor prognosis. Surgery remains the most efficient treatment prior melanoma invasion and metastasis formation. However, therapy becomes a challenge once the cancer cells colonized other tissues. At present, there are two main classes of therapies acting with a certain efficiency on metastatic melanoma: immune check point inhibitors (anti-PD1/PDL1) and targeted therapy such as Vemurafenib. Unfortunately, these therapies are not fully responsive, induce resistance and/or generate unwanted side effects. In this respect, it is important to continue to discover new cancer therapeutics. Here, we show that daphnane diterpenes type of compounds can prevent melanoma metastasis by inhibiting metastasis-associated matrix metalloproteinases expression without cytotoxicity. METHODS Evaluation of the anti-metastasis effect of daphnane diterpenes-rich Thymelaea hirsuta extract (TH) and its bioactive component gnidilatidin was carried out in vitro using B16 murine melanoma cells and in vivo using male C57BL/6 J mice. Global gene expression in B16 cells was done using DNA microarray, validated using real-time PCR, to further understand the effect of daphnane diterpenes, specifically daphnane diterpenoid gnidilatidin. RESULTS Oral administration of daphnane diterpenes-rich Thymelaea hirsuta extract (TH) suppressed MMP2 and MMP9 expression, decreasing lung tumor in mice injected with B16 murine melanoma cells. Validation of these observations in vitro showed reduced B16 cells migration, adhesion, and invasion. Results of microarray analysis of B16 cells treated with daphnane diterpenoid gnidilatidin from TH revealed an upregulation of tumor suppressor Egr1 while inhibiting metastasis-associated genes Id2 and Sytl2 expression. A downregulation of the melanoma oncogene microphthalmia-associated transcription factor (Mitf) was observed, and most likely caused by the inhibition of Id2, a gene that regulated HLH transcription factors such as MITF and also reported to promote tumor cell migration and invasion. CONCLUSIONS Daphnane diterpenes have inhibitory effect on the metastatic potential of B16 melanoma cells, and the results of this study provided evidence for their potential for use in the prevention and inhibition of melanoma metastasis.

UI MeSH Term Description Entries

Related Publications

Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
December 2019, Phytotherapy research : PTR,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
January 2015, Molekuliarnaia biologiia,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
January 2012, Biological & pharmaceutical bulletin,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
June 2004, Melanoma research,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
September 2017, International journal of oncology,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
July 2013, Clinics (Sao Paulo, Brazil),
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
April 2020, Experimental dermatology,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
November 2012, Journal of ethnopharmacology,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
January 2019, BioMed research international,
Myra O Villareal, and Yuki Sato, and Kyoko Matsuyama, and Hiroko Isoda
March 2016, Medical & biological engineering & computing,
Copied contents to your clipboard!